G01N 33/686
Anti-idiotype
Official title: {Anti-idiotype}
G01N33/686 (Anti-idiotype) appears on 149 US grants and 224 published applications in this corpus.
Search patents in G01N- Granted patents
- 149
- Published applications
- 224
- Assignees
- 139
- Inventors
- 486
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 4 | 0 |
| 1988 | 0 | 0 |
| 1989 | 4 | 0 |
| 1990 | 4 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 5 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 4 | 2 |
| 2003 | 2 | 1 |
| 2004 | 0 | 6 |
| 2005 | 2 | 3 |
| 2006 | 2 | 5 |
| 2007 | 1 | 4 |
| 2008 | 3 | 12 |
| 2009 | 0 | 4 |
| 2010 | 2 | 10 |
| 2011 | 1 | 3 |
| 2012 | 3 | 3 |
| 2013 | 5 | 7 |
| 2014 | 4 | 14 |
| 2015 | 7 | 18 |
| 2016 | 7 | 18 |
| 2017 | 17 | 5 |
| 2018 | 4 | 12 |
| 2019 | 3 | 10 |
| 2020 | 9 | 13 |
| 2021 | 3 | 17 |
| 2022 | 3 | 13 |
| 2023 | 12 | 12 |
| 2024 | 3 | 13 |
| 2025 | 9 | 11 |
| 2026 | 7 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Interference-suppressed pharmacokinetic immunoassay28 Jul 2026US 12,693,290 B2Hoffmann-La Roche Inc.
- Anti-vedolizumab antibodies and uses thereof28 Jul 2026US 12,693,298 B1Takeda Pharmaceutical Company Limited
- Methods and materials for identifying and treating membranous nephropathy based on elevated Semaphorin 3B31 Mar 2026US 12,590,165 B2Mayo Foundation for Medical Education and Research
- Complex-specific antibodies and antibody fragments and its use31 Mar 2026US 12,590,172 B2Morphosys AG
- Sensor for detecting biomarkers in a fluid sample and methods of use17 Mar 2026US 12,578,334 B2American University of Beirut
- Vh4-34 antigen-binding molecules17 Sep 2026US 2026/0274993 A1Hummingbird Bioscience Pte. Ltd.
- Depletion of high-abundance plasma proteins using in situ growth of metal-organic frameworks (mofs) for proteomic analysis and biomarker discovery10 Sep 2026US 2026/0266814 A1
- Targeting aberrant o-glycans of iga1 to develop a urinary diagnostic method for iga nephropathy3 Sep 2026US 2026/0259209 A1Buddhist Tzu Chi Medical Foundation
- System and method for analyzing antibody co-formulations6 Aug 2026US 2026/0227390 A1Amgen Inc.
- Sensor for detecting biomarkers in a fluid sample and methods of use23 Jul 2026US 2026/0210963 A1
Most cited
By later US patents
- Method of producing monoclonal anti-idiotype antibody132US 4,699,880 AImmunomedics, Inc. · 1987
- Antibodies to human carcinoma antigen83US 5,693,763 AEpigen, Inc. · 1997
- Monoclonal antibodies to a pan-malarial antigen81US 5,001,225 AGeorgetown University · 1991
- Tumor immunotherapy using anti-idiotypic antibodies75US 4,918,164 AOncogen · 1990
- Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca41US 5,691,151 AThe Regents of the University of California · 1997